View all reports
Lineage Cell Therapeutics, Inc. (LCTX) stock forecast and price target
Find the latest Lineage Cell Therapeutics, Inc. lctx analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
LCTXLineage Cell Therapeutics, Inc.0.8817 +0.0017 (+0.19%)
At close: 07:59PM
Recommendation Rating
2
Analyst Price Targets (6)
Current?0.88
Average?5.00
Low?4.00
High?7.00
Related Research Reports1-2 of 2 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| GWRS,COST,AMP,DLTR,LLY,LCTX,ALIT,AN,MAC | Utilities,Financial Services,Technology,Real Estate,Healthcare,Consumer Defensive,Consumer Cyclical | Argus | Mar 30, 2022 | Upgrade to begin downloading full reports | |
| IPI,HEI-A,KODK,LCTX,IART,ORIC,M | Basic Materials,Healthcare,Industrials,Consumer Cyclical | Argus | Mar 28, 2022 | Upgrade to begin downloading full reports |